MyAverix Finance MyAverix Finance

XETRA · Healthcare

SynBiotic SE (SBX)

Drug Manufacturers - Specialty & Generic

SynBiotic SE (SBX) is listed on XETRA in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-03-22

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for SBX

P/E ratio
18.00

SynBiotic SE (SBX) — FAQ

What is SBX's P/E ratio?

The price-to-earnings (P/E) ratio for SynBiotic SE (SBX) is 18.00 (data as of 2026-03-22).

Does SynBiotic SE pay a dividend?

Dividend yield is not available in the current snapshot for SynBiotic SE (SBX). Check the MyAverix Finance app for the latest dividend data.

What sector is SynBiotic SE in?

SynBiotic SE (SBX) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is SBX listed on?

SBX is listed on XETRA.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Aimed Bio (0009K0) Celltrion (068270) Rznomics (476830)

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play